
Medical Innovations Pathways Takes the Stage at Granite School District’s Career Night
January 25, 2019
Yesterday, Utah’s life sciences companies participating in the Medical Innovations Pathways (MIP) program (www.medicalinnovationspathways.com), gathered at Granite School District as part of the district’s annual Career and Technical Education Open House. The Open House offers students a glimpse into a board range of industries. Representatives from BD, Edwards Lifesciences, Merit Medical, Nelson Laboratories, and Stryker set up company exhibits and made presentations during special medical device and laboratory testing breakout sessions.
“it was a great night,” said Jake Willis, Project Portfolio Manager with Nelson Laboratories. “We were able to talk directly to students and their parents, and help them understand what working in the life sciences industry is all about.”
The MIP program provides students with the opportunity to directly engage with leaders of Utah’s life sciences industry, and earn the Medical Innovations Certificate.
“We want students to enroll in MIP and come visit our facilities,” said Anthea Alono, Human Resources Director for Stryker. “Ultimately, we hope they come work for us and share in our passions for innovation and saving lives.”
The MIP program, now in its third year, is offered to high school seniors in Alpine, Canyons, Davis, Granite, Jordan, and Tooele school districts. In addition to completing required MIP coursework, students enrolled in the program will do company job shadows.
Recent News
- BioUtah’s 2026 Utah Life Sciences Summit Recap
- 2026 Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit
- PROGRESS TRIAL DEMONSTRATES EDWARDS TAVR IS SUPERIOR TO CLINICAL SURVEILLANCE FOR MODERATE AS PATIENTS WITH AT-RISK FEATURES
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
- Utah Business, Government Leaders Deepen Connections in Ireland
- Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test

















